Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Jul 18, 2023

SELL
$1.14 - $1.95 $2,849 - $4,875
-2,500 Reduced 40.98%
3,600 $0
Q1 2023

May 01, 2023

SELL
$1.2 - $2.19 $77,280 - $141,036
-64,400 Reduced 91.35%
6,100 $0
Q4 2022

Feb 07, 2023

SELL
$1.63 - $3.52 $69,112 - $149,248
-42,400 Reduced 37.56%
70,500 $4,000
Q3 2022

Oct 25, 2022

BUY
$0.73 - $3.74 $64,751 - $331,738
88,700 Added 366.53%
112,900 $20,000
Q2 2022

Aug 04, 2022

SELL
$2.2 - $4.2 $40,480 - $77,280
-18,400 Reduced 43.19%
24,200 $2,000
Q1 2022

Apr 14, 2022

SELL
$2.83 - $8.69 $183,101 - $562,243
-64,700 Reduced 60.3%
42,600 $9,000
Q4 2021

Jan 18, 2022

BUY
$8.31 - $14.92 $261,765 - $469,980
31,500 Added 41.56%
107,300 $59,000
Q3 2021

Oct 26, 2021

BUY
$9.15 - $13.28 $693,570 - $1.01 Million
75,800 New
75,800 $61,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $489M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.